Literature DB >> 21763273

Induction of chondrogenic cells from dermal fibroblast culture by defined factors does not involve a pluripotent state.

Hidetatsu Outani1, Minoru Okada, Kunihiko Hiramatsu, Hideki Yoshikawa, Noriyuki Tsumaki.   

Abstract

There is a significant need for cell sources for cartilage regenerative medicine. It has been reported that the combined transduction of two reprogramming factors (c-Myc and Klf4) and one chondrogenic factor (SOX9) directly induces chondrogenic cells from mouse dermal fibroblast (MDF) culture. To gain insights into the process by which cellular characteristics are altered by transduction of c-Myc, Klf4 and SOX9, we examined marker gene expression in the MDF culture at various time points after transduction. The expression of fibroblast-markers was reduced first, followed by an increase in the expression of a chondrocyte-marker. We detected no expression of pluripotent markers at any time point examined. To determine whether or not induced chondrogenic cells go through a pluripotent state after transduction, we analyzed MDFs prepared from Nanog-GFP transgenic mice by monitoring expression of the GFP-labeled pluripotent marker Nanog-GFP in the MDF culture, using time-lapse microscopic observation. Whole-well time-lapse observation revealed that none of the induced chondrogenic cells displayed GFP fluorescence during induction. These results indicate that cells do not undergo a pluripotent state during direct induction of chondrogenic cells from fibroblast culture by transduction of c-Myc, Klf4 and SOX9.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763273     DOI: 10.1016/j.bbrc.2011.06.194

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Advances in Skeletal Dysplasia Genetics.

Authors:  Krista A Geister; Sally A Camper
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-04-22       Impact factor: 8.929

Review 2.  Krüppel-like factors in mammalian stem cells and development.

Authors:  Agnieszka B Bialkowska; Vincent W Yang; Sandeep K Mallipattu
Journal:  Development       Date:  2017-03-01       Impact factor: 6.868

Review 3.  Stem cell-based therapies for osteoarthritis: challenges and opportunities.

Authors:  Brian O Diekman; Farshid Guilak
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

4.  Reprogramming of Dermal Fibroblasts into Osteo-Chondrogenic Cells with Elevated Osteogenic Potency by Defined Transcription Factors.

Authors:  Yinxiang Wang; Ming-Hoi Wu; May Pui Lai Cheung; Mai Har Sham; Haruhiko Akiyama; Danny Chan; Kathryn S E Cheah; Martin Cheung
Journal:  Stem Cell Reports       Date:  2017-05-18       Impact factor: 7.765

Review 5.  Cellular reprogramming for clinical cartilage repair.

Authors:  Britta J H Driessen; Colin Logie; Lucienne A Vonk
Journal:  Cell Biol Toxicol       Date:  2017-01-31       Impact factor: 6.691

6.  Different Chondrogenic Potential among Human Induced Pluripotent Stem Cells from Diverse Origin Primary Cells.

Authors:  Yeri Alice Rim; Yoojun Nam; Narae Park; Hyerin Jung; Yeonsue Jang; Jennifer Lee; Ji Hyeon Ju
Journal:  Stem Cells Int       Date:  2018-01-21       Impact factor: 5.443

7.  Direct induction of chondrogenic cells from human dermal fibroblast culture by defined factors.

Authors:  Hidetatsu Outani; Minoru Okada; Akihiro Yamashita; Kanako Nakagawa; Hideki Yoshikawa; Noriyuki Tsumaki
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 8.  Gene modification of mesenchymal stem cells and articular chondrocytes to enhance chondrogenesis.

Authors:  Saliya Gurusinghe; Padraig Strappe
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

Review 9.  Osteochondral Tissue Engineering: The Potential of Electrospinning and Additive Manufacturing.

Authors:  Andreia M Gonçalves; Anabela Moreira; Achim Weber; Gareth R Williams; Pedro F Costa
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.